Biostatistics Core
Biostatistics Core
批准号:
8589114
负责人:
MARK KESTER
金额:
$2.3万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-10 至 2018-08-31
关键词:
Advisory CommitteesAnimalsAreaBioinformaticsBiological MarkersBiological SciencesBiometryBiostatistics CoreClinicalClinical SciencesCommunicationCommunitiesComputer HardwareComputer softwareConfidentialityDNADataData AnalysesData CollectionDatabasesDoseEnsureExperimental DesignsFloorHealth SciencesHuman ResourcesInstitutesInstitutionKnowledgeLearningLocationMalignant NeoplasmsManuscriptsMetabolismMethodologyPreparationProteomicsPublic HealthPublicationsResearchResearch PersonnelResourcesSample SizeSecureSecurityServicesSphingolipidsWorkcost effectivenessdata integritydata managementdata sharingdesignexperienceimprovedmeetingsmemberprogramsresearch studystatistical servicesymposiumtool
中文摘要
生物统计核心是所有四个项目的生物统计支持的协调中心。核心将定期提供有关实验设计的建议,例如终点的选择、样本量和功效以及动物和剂量的最佳分配。核心在一个安全的中央位置以跨项目一致的格式处理四个项目的数据管理。核心将进行专家统计分析,以最佳方式回答研究问题并代表最先进的实践。该核心还将促进与一般科学界的数据共享。
核心小组由两名经验丰富的生物统计学家组成,他们与项目研究人员有日常工作关系。他们的办公室位于癌症研究所大楼的三楼,靠近大多数项目研究人员。核心生物统计学家是P01应用程序的组成部分,他们负责实验设计、分析初步数据并为每个项目制定详细的量身定制的统计计划。核心生物统计学家在AML项目中共同努力学习临床和生物科学,以提供最强有力的统计服务。核心可以访问所有需要的软件,如Microsoft Office 2007、SAS 9.3和R。一个专门的生物统计学核心为计划项目调查人员提供了方便和有保障的访问,也使生物统计学家能够在科学知识和生物统计学专业知识方面专注于项目领域
一个专门的核心提供及时和高质量的生物统计服务作为其重点。由于所有核心人员积累的经验以及四个项目中的每一个项目的综合设施和资源,成本效益得到提高。生物统计学核心还作为公共卫生科学部生物统计学,数据管理和计算方面更大资源的接口。不需要额外的计算机硬件和软件。
英文摘要
The Biostatistics Core serves as the focal point of biostatistics support for all the four Projects. The Core will provide regular advice on experimental design such as selection of end points, sample size and power, and optimal allocation of animal and dose. The Core handles data management of the four Projects in a secure central location and in a format consistent across Projects. The Core will perform expert statistical analyses that optimally answer the research question and represent state of the art practice. The Core will also facilitate data sharing with the general scientific community.
The Core is staffed by two experienced biostatisticians who have daily working relationships with the Project investigators. Their offices are on the third floor of the Cancer Institute building, in close proximity to most of the Program Project investigators. The Core biostatisticians have been an integral part of the P01 application through working on experimental design, analyzing preliminary data and developing a detailed and tailored statistical plan for each Project. The Core biostatisticians have made a concerted effort to learn the clinical and biological science in this AML Program Project so as to provide the strongest statistical service. The Core has access to all needed software such as Microsoft Office 2007, SAS 9.3 and R. A dedicated Biostatistics Core provides easy and guaranteed access for the Program Project investigators and also allows biostatisticians to specialize in the Project areas, in terms of the scientific knowledge and in biostatistics expertise
A dedicated Core provides timely and high quality biostatistics service as its focus. Cost-effectiveness is enhanced because the cumulative experience of all Core personnel and the combined facilities and resources are available to each of the four Projects. The Biostatistics Core also serves as an interface to the larger resources in biostatistics, data management and computing in the Department of Public Health Sciences. No additional computer hardware and software are needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ceramide Nanoliposomes in Combination with Focused Ultrasound for Treating Breast Cancer
-
批准号:9750255
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2018
-
负责人:MARK KESTER
-
依托单位:
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
-
批准号:10206045
-
项目类别:
-
资助金额:$55.31万
-
财政年份:2017
-
负责人:MARK KESTER
-
依托单位:
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
-
批准号:9403358
-
项目类别:
-
资助金额:$53.12万
-
财政年份:2017
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:9020214
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Clinical Trial of Ceramide nanoLiposomes in AML
-
批准号:10160825
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Administrative Core
-
批准号:8589115
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8827284
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Ceramide Metabolism in AML
-
批准号:8554594
-
项目类别:
-
资助金额:$30.57万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8638905
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8435991
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:10160824
-
项目类别:
-
资助金额:$199.55万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:8552151
-
项目类别:
-
资助金额:$198.9万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Acid Ceramidase in AML
-
批准号:8554595
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:8732613
-
项目类别:
-
资助金额:$192.93万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:9248264
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Sphingosine Kinase in AML
-
批准号:8554596
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:7903885
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:8106211
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:7732069
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
PKC zeta as a Target for Ceramide
-
批准号:7148916
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2006
-
负责人:MARK KESTER
-
依托单位:
海外基金